Cargando…
Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village
BACKGROUND AND AIMS: As indicated by the World Health Organization (WHO), Egypt is positioned as the country with the world's highest prevalence of Hepatitis C virus (HCV). HCV is transmitted through unexamined blood transfusions, different employments of syringes, and poor cleansing, as per th...
Autores principales: | Ahmed, Ossama Ashraf, Safwat, Eslam, Khalifa, Mohamed Omar, Elshafie, Ahmed I., Fouad, Mohamed Hassan Ahmed, Salama, Mohamed Magdy, Naguib, Gina Gamal, Eltabbakh, Mohamed Mahmoud, Sherief, Ahmed Fouad, Abd-Elsalam, Sherief |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884208/ https://www.ncbi.nlm.nih.gov/pubmed/29755792 http://dx.doi.org/10.1155/2018/9616234 |
Ejemplares similares
-
Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
por: Ahmed, Ossama A, et al.
Publicado: (2018) -
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
por: Omran, Dalia, et al.
Publicado: (2018) -
Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
por: Ahmed, Ossama A, et al.
Publicado: (2018) -
Successful treatment of hepatitis C genotype 4 using sofosbuvir, daclatasvir, simeprevir and ribavirin in Egyptian patients with direct-acting antiviral agent treatment failure
por: Mohamed, Hala, et al.
Publicado: (2022) -
Persistent Colonic Schistosomiasis among Symptomatic Rural Inhabitants in the Egyptian Nile Delta
por: Ahmed, Mohamed Hussien, et al.
Publicado: (2021)